VTC to lead a $2.3 million study on subclinical TB
The Vanderbilt TB Center will lead a two-year, $2.3 million project funded by CRDF Global, to conduct research on the prevalence and incidence of subclinical tuberculosis(TB) in close contacts and evaluate novel biomarkers and diagnostic tests for subclinical TB. The true prevalence and incidence of subclinical TB in close TB contacts is unclear, and the optimal diagnostic method for subclinical TB is unknown.